UBC launches digital patient engagement platform

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Urupong)
(Image: Getty/Urupong)

Related tags: patient engagement, United BioSource, UBC, DIA

The HIPAA-compliant patient engagement digital platform was developed for clinical trial participants who recently joined or finished a study, providing resources across a range of health conditions.

weLink – which United BioSource (UBC) is releasing at the 2019 DIA Global Annual Meeting next week – also can be used to find current research studies and enables sponsors to share plain language clinical trial results, according to United BioSource (UBC).

For researchers, the platform serves as an active participant database through which patients can be re-engaged and potentially recruited for future studies in addition to Risk Evaluation and Mitigation Strategies (REMS), outcomes research, and market research.

Additionally, weLink allows sponsors to garner patient input to better understand the “benefit-risk calculations”​ patients make when considering participating in a clinical trial, according to the company.

UBC is among the contract research organizations (CROs) which in 2018 formed​ an industry standards group to improve clinical trial execution and collaboration among sponsors and CROs.

Related topics: Clinical Development

Related news

Show more

Follow us

Products

View more

Webinars